中国医药行业药品研发的现状与思考  

Current Situation and Thinking of Drug Research and Development in China's Pharmaceutical Industry

作　　者：郑丽 杨灿 杨玉军 王允雨 于伟东 樊丽娜 史乾 郝继成 Zheng Li;Yang Can;Yang Yujun;Wang Yunyu;Yu Weidong;Fan Lina;Shi Qian;Hao Jicheng(Heze City Development Investment Co.,Ltd,Heze 274000,China;Shandong Danhong Pharmaceutical Co.,Ltd.,Heze 274000,China;Shandong Buchang Pharmaceutical Co.,Ltd.,Heze 274000,China;Shandong Kangai Pharmaceutical Co.,Ltd.,Heze 274000,China)

机构地区：[1]菏泽市城市开发投资有限公司,山东菏泽274000 [2]山东丹红制药有限公司,山东菏泽274000 [3]山东步长制药股份有限公司,山东菏泽274000 [4]山东康爱制药有限公司,山东菏泽274000

出　　处：《山东化工》2020年第19期254-255,共2页Shandong Chemical Industry

摘　　要：本文介绍了我国药品研发的现状,分析了我国药品研发存在的主要问题,并针对存在的主要问题提出了一点建议。当今,我国医药行业及药品研发机遇与挑战并存,我们要勇抓机遇,直面挑战,做出保质保量的良药。This paper introduces the current situation of drug research and development in China,analyzes the main problems existing in drug research and development in China,and puts forward some suggestions for the main problems.Nowadays,opportunities and challenges coexist in China's pharmaceutical industry and drug research and development.We should seize the opportunities,face the challenges and make quality and quantity guaranteed medicines.

关 键 词：药品研发 知识产权 风险识别 

分 类 号：F426.7[经济管理—产业经济]